Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Issue : PJ September 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Side effects for Tracleer Subscription

    22 SEP 2015 14:00

    Aminotransferase elevations associated with hepatitis (including possible exacerbation of underlying hepatitis) or jaundice or both has been added as an uncommon adverse reaction in the summary of product characteristics for Tracleer (bosentan monohydrate; Actelion).

  • Guide to new registration assessment Subscription

    22 SEP 2015 13:59

    The General Pharmaceutical Council (GPhC) has published a guide to the new registration assessment, which candidates will sit for the first time in 2016. The guide contains information about the format of the assessment and details about the registration assessment framework. It is available ...

  • Antimicrobial pharmacist Philip Howard (pictured) tells how point-of-care tests could reduce inappropriate prescribing of antibiotics during the 2015 Royal Pharmaceutical Society Conference

    Point-of-care testing for infections vital in fight against antimicrobial resistance Subscription

    21 SEP 2015 12:26 By Janna Lawrence

    Point of care tests are one of the most crucial developments in the fight against antimicrobial resistance, according to a leading antimicrobial pharmacist.

  • Canesten range updated Subscription

    21 SEP 2015 11:58

    Bayer is updating its range of Canesten products. There will be changes to the naming and packaging, with the updated products being introduced from July 2015 until early 2016. The active ingredients and product composition will remain the same.

  • The Drugs for Neglected Diseases initiative has announced that it aims to spend €650m to deliver treatments for up to 10 diseases. In the image, tsetse mosquitos pictured on a researcher's hand are responsible for the African sleeping sickness

    R&D plan announced for drugs for neglected diseases Subscription

    18 SEP 2015 13:45

    The Drugs for Neglected Diseases initiative, a non-profit research and development organisation, has announced that it aims to spend €650m over the next eight years to deliver 16–18 new treatments.

  • Thursday 15 October: RPS Faculty webinar Subscription

    11 SEP 2015 11:13

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: what is the best type of evidence? How much detail do I need to enter into my portfolio? Who should I ask to provide a peer testimonial? Do I need to cover all the competencies? Online 7–8pm. To find out more information and to register and access the webinar, visit the RPS website.

  • Thursday 1 October: RPS Faculty webinar Subscription

    11 SEP 2015 11:12

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: what is the best type of evidence? How much detail do I need to enter into my portfolio? Who should I ask to provide a peer testimonial? Do I need to cover all the competencies? Online 1–2pm. To find out more information and to register and access the webinar, visit the ...

  • Generic erythromycin lactobionate available Subscription

    11 SEP 2015 11:05

    Generic erythromycin lactobionate 1g will replace the brand Erythrocin from Amdipharm Mercury from 21 September 2015.  

  • Generic hydrocortisone sodium phosphate solution available Subscription

    11 SEP 2015 11:04

    Generic hydrocortisone sodium phosphate solution for injection 100mg/ml and 500mg/5ml replaces the brand Efcortesol injection from Amdipharm Mercury.

  • Bladder cancer learning tool from NICE Subscription

    11 SEP 2015 11:03

    The National Institute for Health and Care Excellence (NICE) has launched a new online learning tool about bladder cancer. The tool, which was developed by the Centre for Pharmacy Postgraduate Education, supports the implementation of the NICE clinical guideline on bladder cancer. It is available for free from the NICE website.  

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.